You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

September 4, 2018

Vietnam: New Law on Competition Impacts IP

Managing Intellectual Property

On June 12, 2018, Vietnam passed a new Law on Competition that will take effect on July 1, 2019, replacing the Law on Competition of 2004. The new law brings about several changes affecting intellectual property. Notably, it eliminates many of the discrepancies between the current 2004 Competition Law and the Intellectual Property Law in dealing with IP-related unfair competition.

Acts of Unfair Competition

A weakness of the 2004 Competition Law and its subordinate regulations (such as Decree No. 71/2014/ND-CP) is that they overlap with provisions on competition found in other laws. For example, both the 2004 Competition Law and the IP Law have provisions concerning acts of cybersquatting, the use of misleading trade indications, and the unauthorized use of a trademark by an agent, and both provide that the infringement of trade secrets is an act of unfair competition. This has led to confusion for law enforcement agencies and rights holders as to which enforcement mechanisms should be employed in taking action against unfair competition relating to IP.

The new Competition Law no longer sets out acts of unfair competition that are already covered by the IP Law. Instead, the new law expressly states that when there are discrepancies between the Competition Law and the related unfair competition provisions of another law, the provisions of the other law will prevail. This will be a big step toward clarifying who will enforce the laws on unfair competition in practice. When the new Competition Law takes force, rights holders can rely solely on the IP Law.

Secrets in Business

The new Competition Law seems to introduce a new statutory term, “secrets in business” (bí mật trong kinh doanh). The new law considers infringement of these “secrets in business” to amount to unfair competition, but it does not define this term. The term is similar to the statutory term “trade secret” (bí mật kinh doanh) defined in the IP Law. However, given the principle that the new law does not repeat acts of unfair competition provided in other laws, it is uncertain whether the term “secrets in business” has an equivalent meaning to “trade secret” in the IP Law, or is something entirely new. As a matter of practice, the government will roll out decrees to guide the implementation of new laws. In these decrees, the government should clarify the meaning of this term.

Court Jurisdiction

The prevailing competition laws defer to the Civil Code for resolving non-contractual damages related to unfair practices. Particularly, if unfair practices cause damage to the lawful rights and interests of others, the offenders are required to compensate for such loss in accordance with the civil laws. Under the Civil Procedure Code, disputes over compensation for non-contractual damage fall under the civil courts’ jurisdiction. To resolve these disputes, the court must assess the unfair competition acts as one of the bases for determining the damages.

The new Competition Law no longer expressly refers to the civil laws as the legal tools to deal with unfair competition, triggering concern about whether the civil court still has jurisdiction to rule on unfair competition. However, the new law does not expressly obviate the court’s jurisdiction over acts of unfair competition that cause harm to the legitimate rights and interests of competitors. In addition, the Law on Promulgation of Legal Documents prevents laws from repeating regulations that are mentioned in other laws. The civil laws already expressly allow companies to initiate suits to generally protect their rights and interests. Thus, the new Competition Law should be interpreted in a way not to preclude the court’s power to deal with acts of unfair competition.

Other Changes

The new law establishes a new state agency, the National Competition Commission, to be in charge of dealing with antitrust and unfair competition practices set out in the law. For unfair competition acts covered in other laws, the respective authorities empowered by such laws would have power. As such, to curb unfair competition under laws relating to IP, companies can rely on administrative enforcement bodies, civil courts, or arbitration as set forth in the IP Law.

The new law also shortens the timeframe for administrative bodies, namely the National Competition Commission, to deal with unfair competition. Under the new law, the maximum time is just 60 days, with an option to extend another 45 days. This would only apply to unfair competition acts not falling under the IP Law. On the whole, the new Competition Law marks progress in eradicating discrepancies between laws on competition and IP that have caused uncertainty for years. However, certain issues still need clarification, such as compulsory licensing and “secrets in business,” for the law to be easily implemented in practice.

RELATED INSIGHTS​ 

July 14, 2025
Life sciences specialists from Tilleke & Gibbins have updated the firm’s guide to pharmaceutical data exclusivity regulations and practices in Southeast Asia. This guide contains quick-reference information on the availability of data exclusivity protections and limitations in Cambodia, Indonesia, Laos, Malaysia, Myanmar, Thailand, and Vietnam. Developing and launching a new drug on a commercial scale requires an enormous amount of time and investment in research and development (R&D), including pre-clinical testing and clinical trials. When considering the aggregate amount of drug development costs, it is important to recognize that this includes not only the investment in developing new drugs that get approved by a government food and drug regulator and are successfully brought to market, but also the R&D expenditures on a large number of potential pharmaceutical compounds and products that never actually make it to market. In particular, considerable investment is required in order to conduct and produce clinical trial data—to prove safety, efficacy and effectiveness of a new drug—that would warrant marketing approval by the regulatory authority. Such data is proprietary in nature and highly valuable for a research-based pharmaceutical company that develops an original drug. On the other hand, patent law typically confers generic drug manufacturers with the ability to engage in various preparatory activities with a view to obtaining marketing approval for a generic product before the patent for the original drug expires (commonly known as a “Bolar provision”). Since a generic drug maker may submit an application for marketing approval of a generic product before the relevant patent expires, the extent to which the drug originator’s data submitted to the regulatory authority is protected—or in other words, the extent to which the generic company may rely on the drug originator’s previously filed data, which underpins the safety and efficacy of the drug, to support
July 10, 2025
For companies and individuals doing business in Vietnam, a common question is whether electronic signatures (e-signatures) are legally recognized under Vietnamese law. This matter is governed by Law No. 20/2023/QH15 on Electronic Transactions issued on June 22, 2023 (ETL 2023) and its guiding legal documents such as Decree No. 23/2025/ND-CP dated February 21, 2025, and Circular 06/2024/TT-BTTTT dated July 1, 2024 (Circular 06). Recognition of Validity of E-signatures in Vietnam As a general principle, the ETL 2023 confirms that an e-signature cannot be denied legal validity solely due to its electronic form. The law categorizes e-signatures into three types: Type 1: Specialized e-signatures for organizations Type 2: Public digital signatures for individuals and organizations Type 3: Specialized digital signatures for government agencies Among these types, only secure specialized e-signatures (a secure e-signature of type 1) and digital signatures (type 2) are explicitly granted the same legal validity as handwritten (wet) signatures. This distinction is particularly important in legal disputes and for transactions with government agencies. (For more details, please refer to our previous article.) Domestic e-signatures A domestic organization can choose to use secure specialized e-signatures (type 1) and/or digital signatures (type 2) while a Vietnam-based individual can choose digital signatures (type 2) for their transactions—particularly for those involving government agencies and transactions of high value and complexity which require stronger legal protection. Specialized e-signatures (type 1) can be created by the organizations themselves, and additionally must be “secure” to be explicitly recognized as having the same legal validity as handwritten signatures. For clarity, “secure” specialized e-signatures are those certified (granted a safety certificate) by the Ministry of Science and Technology (MST). (This was formerly the responsibility of the Ministry of Information and Communications, which was merged with MST under Vietnam’s 2025 administrative restructuring.) Digital signatures (type 2) are
July 4, 2025
On July 3, 2025, the Trade Competition Commission of Thailand (TCCT) officially announced an invitation for stakeholders to participate in a public survey to gather feedback on the flexibility and appropriateness of credit terms across different business sectors for goods and services. The TCCT initially introduced guidelines on unfair trade practices related to credit terms applicable to small and medium-sized enterprises (SMEs) in 2021, with amendments following in 2022. The guidelines have had a wide impact, as businesses have had to adapt their payment procedures and practices, particularly those for dealing with SMEs, to comply with the guidelines. The TCCT is now seeking comprehensive feedback from businesses and other stakeholders to evaluate the effectiveness and practicality of these guidelines. The collected responses may potentially lead to future amendments aimed at enhancing fairness and efficiency in business transactions. To summarize the core principles, the guidelines aim to improve the liquidity and cash flow of SMEs, stipulating payment terms of: Within 30 days for agricultural products or primary agricultural processing involving non-complex production. Within 45 days for trade, manufacturing, and service sectors. The guidelines also identify practices deemed unfair, including: Unjustified delays in payment beyond agreed credit terms. Changes to credit terms or contractual conditions without at least 60 days’ advance notice. Other unfair conduct or credit term conditions that impose excessive burdens on an SME. Interested stakeholders are encouraged to submit their feedback through the TCCT’s online survey form available via their official public media channels. The survey is open for responses until July 20, 2025.
June 30, 2025
Vietnam is making notable strides in decentralization, aiming to grant greater autonomy to local government entities to streamline administrative procedures. As part of this effort, the government issued Decree No. 133/2025/ND-CP on decentralization of state management of the Ministry of Science and Technology dated June 12, 2025 (Decree 133). Effective from July 1, 2025, Decree 133 decentralizes and delegates numerous state management functions—including in intellectual property (IP) and technology transfer—to provincial-level People’s Committees (PCs). This reform signals a profound shift in how IP rights are administered and enforced across Vietnam. While this offers new opportunities for IP owners, agents, and innovators, it also introduces additional operational complexities. Impact on IP and Technology Transfer Decree 133 significantly reallocates responsibilities in IP and technology transfer, primarily to provincial-level PCs. Provincial PCs and other provincial authorities are now empowered to handle a wide range of tasks, including but not limited to the following: Issuance of duplicates and reissuance of certificates of registration. Registration of license agreements for the transfer of usage rights for industrial property objects (e.g., trademarks, patents) and recording amendments, extensions, or early terminations of such agreements. Enforcing decisions on compulsory licensing of patent use rights. Evaluation and approval of technology transfer contracts—a key step in facilitating localized technological advancements. Permitting the establishment of foreign-invested scientific organizations and their branches, to encourage foreign direct investment in local R&D and technology development. Approval of provincial-level R&D tasks, aligning with local socio-economic development priorities. Legal Implications The decentralization and delegation brought forth by Decree 133 carry several significant legal implications: Echoing Decree 133, the Intellectual Property Office of Vietnam issued Notification No. 2351/TB-SHTT on June 26, 2025, announcing the cessation of 19 administrative procedures at the national level. Specifically, from July 1, 2025, the IP Office will no longer accept requests related